ARLINGTON, Va., Dec. 1 /PRNewswire/ -- BioInformatics, LLC announces the release of its newest report, The Market Outlook for Research Products in FY2010. The 8.2 billion dollars appropriated to...
MUNDELEIN, Ill., April 22 /PRNewswire/ -- Sysmex America, Inc. today announced the successful completion of Mercy Medical Center's (Canton, OH) beta studies for its integrated hematology and A1C...
HERCULES, Calif., Feb. 22 /PRNewswire-FirstCall/ -- Bio-Rad Laboratories, Inc. (Amex: BIO; BIOb), a multinational manufacturer and distributor of life science research products and clinical...
HERCULES, Calif., Feb. 1 /PRNewswire-FirstCall/ -- Bio-Rad Laboratories, Inc. (Amex: BIO; BIOb), a multinational manufacturer and distributor of life science research products and clinical...
HERCULES, Calif., Jan. 4 /PRNewswire-FirstCall/ -- Bio-Rad Laboratories, Inc. (Amex: BIO; BIO.B) announced that it has renewed a collaboration agreement with the Institut Pasteur of Paris...
HERCULES, Calif., Nov. 22 /PRNewswire-FirstCall/ -- Bio-Rad Laboratories, Inc. (AMEX: BIO; BIOb), a multinational manufacturer and distributor of life science research products and clinical...
Medical Decision Support Software to be Used With BioPlex(R) 2200 ANA Screen Kit HERCULES, Calif., Nov. 16 /PRNewswire-FirstCall/ -- Bio-Rad Laboratories, Inc. (Amex: BIO; BIOb) announced today...
International Scientific Experts to Discuss Human TSE Strains MARNES-LA-COQUETTE, France, Nov. 14 /PRNewswire-FirstCall/ -- Bio-Rad Laboratories, Inc. (AMEX: BIO; BIOb), a multinational...
HERCULES, Calif., Nov. 3 /PRNewswire-FirstCall/ -- Bio-Rad Laboratories, Inc. (AMEX: BIO; BIOb), a multinational manufacturer and distributor of life science research products and clinical...
Companies to Investigate Development of Another Novel Microfluidic System HERCULES, Calif. and HOPKINTON, Mass., Oct. 25 /PRNewswire-FirstCall/ -- Bio-Rad Laboratories, Inc. (Amex: BIO; BIOb...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0.005 | 0.005 | 0.005 | 0 | 0 | CS |
4 | 0 | 0 | 0.005 | 0.005 | 0.005 | 0 | 0 | CS |
12 | 0 | 0 | 0.005 | 0.005 | 0.005 | 0 | 0 | CS |
26 | 0 | 0 | 0.005 | 0.005 | 0.005 | 0 | 0 | CS |
52 | 0 | 0 | 0.005 | 0.01 | 0.005 | 1387 | 0.00516518 | CS |
156 | -0.03 | -85.7142857143 | 0.035 | 0.04 | 0.005 | 8665 | 0.01385888 | CS |
260 | -0.175 | -97.2222222222 | 0.18 | 0.19 | 0.005 | 24075 | 0.05611551 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales